ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,918,413 | +80541.4% | 140,039 | -7.3% | 0.19% | -13.5% |
| Q2 2023 | $3,619 | -9.2% | 151,107 | -28.6% | 0.22% | -12.2% |
| Q1 2023 | $3,986 | +20.0% | 211,777 | +1.5% | 0.24% | +19.5% |
| Q4 2022 | $3,323 | -99.9% | 208,749 | +4.4% | 0.20% | -4.7% |
| Q3 2022 | $3,273,000 | +17.4% | 200,032 | +1.1% | 0.22% | +24.3% |
| Q2 2022 | $2,789,000 | -45.5% | 197,915 | -6.4% | 0.17% | -36.4% |
| Q1 2022 | $5,122,000 | +15.4% | 211,492 | +11.2% | 0.27% | +24.8% |
| Q4 2021 | $4,438,000 | +47.2% | 190,155 | +4.8% | 0.22% | +38.0% |
| Q3 2021 | $3,014,000 | -26.5% | 181,463 | +8.0% | 0.16% | -27.9% |
| Q2 2021 | $4,100,000 | -0.1% | 168,099 | +5.6% | 0.22% | -11.3% |
| Q1 2021 | $4,105,000 | – | 159,124 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |